Results 151 to 160 of about 41,923 (267)

Treat Foot Ulcers Conservatively [PDF]

Deutsches Ärzteblatt international, 2017
openaire   +2 more sources

Comparative Real‐World Effectiveness of Anti‐TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA‐IBD Registry in Germany

Alimentary Pharmacology &Therapeutics, EarlyView.
A pooled analysis from the prospective UMBRELLA‐IBD registry in Germany (n = 1567) showed comparative real‐world effectiveness in treatment persistence and clinical remission of anti‐TNF, Ustekinumab and Vedolizumab in Crohn's disease patients over 24 months.
Arne Bokemeyer, Florian Tran, Sandra Plachta‐Danielzik, Elena Gilman, Thomas Wenske, Matthew Gaskins, Stefan Schreiber, Bernd Bokemeyer   +7 more
wiley   +1 more source

DFU-GCNet: a global context-enhanced inception network for robust and interpretable diabetic foot ulcer classification. [PDF]

Front Digit Health
Bhuiyan MTA, Rahman MA, Noori FM, Uddin MZ, Masum AKM.   +4 more
europepmc   +1 more source

FDX1 Depletion Activates CD8+ T Cell Antitumor Immunity by Promoting DMBT1 Secretion in Cuproptosis of Colorectal Cancer

Cancer Science, EarlyView.
Elesclomol‐induced cuproptosis potently activates both innate and adaptive antitumor immunity, especially CD8+ T cell immunity. FDX1 serves as a central regulator of CD8+ T cell functionality through DMBT1 downregulation during cuproptosis in colorectal cancer.
Jieqiong Wu, Zaixi Lian, Mingzhou Li, Xingtu Qin, Xiaoyu Lei, Lihua Yang, Lin Bing, Qiuyue Li, Lingyan Zhou, Zhiyang Ma, Xuemei Xu, Jinghao Huang, Zilong Chen, Lijie Chen, Lingjie Zhang, Zhiyuan Xiao, Xiangyu Jian, Xiaoqin Zhang, Yanqing Ding, Yaping Ye, Li Liang, Hongli Jiao, Shuyang Wang   +22 more
wiley   +1 more source

A cross-sectional clinical analysis on diabetic foot ulcer and associated risk management. [PDF]

Indian J Pharmacol
Shamsudeen MA, Gopinath SCB, Zulkiple MZH.   +2 more
europepmc   +1 more source

Understanding Rheumatoid Arthritis‐Oral Health Perceptions Around Diagnosis and the Early Disease Course: A Phenomenological Approach

Community Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives To explore how Dutch adults with rheumatoid arthritis (RA) perceive their oral health around the diagnostic process and the early disease course. The primary objective was to describe these perceptions in depth, and a secondary objective was to identify areas for future patient‐centred research.
Nadine Isabel Bhagwandas, Lotte Arwen van de Stadt, Johanna Margaretha Kroese   +2 more
wiley   +1 more source

Predicting Diabetic Foot Ulcer Outcomes: Machine Learning-Based Refinement of IWGDF-Approved Classifications for Outpatient Services. [PDF]

Endocrinol Diabetes Metab
Mostafavi F, Amini MR, Mehrabi Y, Rezvani M, Toutounchi M, Hashemi Nazari SS.   +5 more
europepmc   +1 more source

Diagnostic Utility of PRAME Immunohistochemistry for Distinguishing Acral Melanoma From Acral Melanocytic Nevi

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Introduction Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry helps distinguish non‐acral melanocytic lesions, but few studies have addressed its value in acral lesions. We aimed to identify an optimal PRAME cut‐off score to differentiate acral melanoma (AM) from acral melanocytic nevi (AMN).
Kritsada Phatcharamaneepakorn, Panitta Sitthinamsuwan, Penvadee Pattanaprichakul, Manasmon Chairatchaneeboon, Nutcha Yodrabum   +4 more
wiley   +1 more source

Platelet-rich plasma combined with multimodal therapy for diabetic foot ulcer with tophi: a case report. [PDF]

Front Clin Diabetes Healthc
Duan X, Sun X, Liu Y, Chen M, Dong L.
europepmc   +1 more source

Histopathologic Characterization of Cutaneous Oxalosis Mimicking Calciphylaxis: Diagnostic Pitfalls and Polarized Light Evaluation

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Cutaneous oxalosis is an uncommon manifestation of primary hyperoxalosis, which can often resemble other cutaneous manifestations of end stage renal disease (ESRD), particularly calciphylaxis. We report the case of a 46 year old female with primary hyperoxaluria type one (PH1) believed to be well‐controlled on lumasiran, a small interfering ...
Shrina Patel, Brad Graham, Kaci Reaves, Mya Phelps   +3 more
wiley   +1 more source